An anti-HER2 antibody conjugated with monomethyl auristatin E is highly effective in HER2-positive human gastric cancer
2016 · Cancer Biology & Therapy · 91 citations
https://doi.org/10.1080/15384047.2016.1139248
J
Jing Jiang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
16
Papers
342
Citations
8
h-index
7
i10-index
Jing Jiang is an academic researcher from Jiangsu Cancer Hospital. The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & HER2/EGFR in Cancer Research & Glycosylation and Glycoproteins Research. The author has an h-index of 8, co-authored 14 publications.
ORCID: 0009-0005-3137-5811Papers by this author
worksPreclinical safety profile of disitamab vedotin：a novel anti-HER2 antibody conjugated with MMAE
2019 · Toxicology Letters · 45 citations
https://doi.org/10.1016/j.toxlet.2019.12.027
Preclinical safety profile of RC88-ADC：a novel mesothelin-targeted antibody conjugated with Monomethyl auristatin E
2021 · Drug and Chemical Toxicology · 12 citations
https://doi.org/10.1080/01480545.2021.2005085
A bispecific antibody targeting HER2 and CLDN18.2 eliminates gastric cancer cells expressing dual antigens by enhancing the immune effector function
2024 · Investigational New Drugs · 8 citations
https://doi.org/10.1007/s10637-024-01417-3
Application of problem‐oriented model combined with situational simulation teaching method in the training of intravenous infusion skills for pediatric rotation nurses
2026 · Precision Medical Sciences · 0 citations
https://doi.org/10.1002/prm2.70020
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat